Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays
出版年份 2018 全文链接
标题
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays
作者
关键词
-
出版物
Viruses-Basel
Volume 10, Issue 11, Pages 655
出版商
MDPI AG
发表日期
2018-11-23
DOI
10.3390/v10110655
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mortality Among Confirmed Lassa Fever Cases During the 2015–2016 Outbreak in Nigeria
- (2018) Maryam Ibrahim Buba et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens
- (2018) Xiao Tong et al. ANTIVIRAL RESEARCH
- Lassa fever in Nigeria: the great unknown
- (2018) Talha Burki LANCET
- Deadly Lassa-fever outbreak tests Nigeria's revamped health agency
- (2018) Amy Maxmen NATURE
- Nigeria hit by unprecedented Lassa fever outbreak
- (2018) Leslie Roberts SCIENCE
- Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses
- (2018) Masaharu Iwasaki et al. PLoS Pathogens
- Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1
- (2018) May Kwang-Mei Wang et al. PLoS Pathogens
- Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018
- (2018) Katherine J. Siddle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis
- (2017) David M Pigott et al. LANCET
- Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
- (2017) Chad E Mire et al. NATURE MEDICINE
- An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions
- (2017) Qianqian Li et al. VACCINE
- Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems
- (2016) Stephen R. Welch et al. ANTIVIRAL RESEARCH
- A cell-based high-throughput protocol to screen entry inhibitors of highly pathogenic viruses with Traditional Chinese Medicines
- (2016) Yong Yang et al. JOURNAL OF MEDICAL VIROLOGY
- Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
- (2016) James E. Robinson et al. Nature Communications
- Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices
- (2016) Steven Mazur et al. Jove-Journal of Visualized Experiments
- Past, present, and future of arenavirus taxonomy
- (2015) Sheli R. Radoshitzky et al. ARCHIVES OF VIROLOGY
- Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
- (2015) Lisa Oestereich et al. JOURNAL OF INFECTIOUS DISEASES
- Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication
- (2015) Nhi Ngo et al. JOURNAL OF VIROLOGY
- Mapping the zoonotic niche of Lassa fever in Africa
- (2015) Adrian Q. N. Mylne et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
- (2015) David Safronetz et al. PLoS Neglected Tropical Diseases
- The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
- (2015) David Safronetz et al. Scientific Reports
- A Host-Oriented Inhibitor of Junin Argentine Hemorrhagic Fever Virus Egress
- (2014) J. Lu et al. JOURNAL OF VIROLOGY
- Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone
- (2014) A. Dahmane et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL-4 pathogens
- (2014) Peter B. Jahrling et al. Pathogens and Disease
- Lead optimization of an acylhydrazone scaffold possessing antiviral activity against Lassa virus
- (2013) James R. Burgeson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January–March 2012)
- (2013) Nnennaya A. Ajayi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Mice Lacking Functional STAT1 Are Highly Susceptible to Lethal Infection with Lassa Virus
- (2013) N. E. Yun et al. JOURNAL OF VIROLOGY
- Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole
- (2012) Dongcheng Dai et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus
- (2011) Stephan Ölschläger et al. ANTIVIRAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started